Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

Dupixent (dupilumab) is a brand-name injection that’s prescribed for treating asthma. This article covers topics such as side effects, dosage, and how Dupixent works. Dupixent is available as a ...

Dupixent pen and Dupixent syringe are used to give Dupixent doses by subcutaneous injection. Dupixent pen and syringe share several features but also have some differences, including needle ...

These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...

Global healthcare company Sanofi and Regeneron Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injection to patients suffering from ...

Adverse events more commonly observed with Dupixent compared to placebo were injection site reactions and COVID-19 infection. Published first on TheFly – the ultimate source for real-time ...

US FDA Approves Dupixent Injections For People Struggling With COPD Symptoms Patients were first given blood tests to find out the type of attacks they were having - with those suffering an ...

Dupixent was cleared by the US FDA for adults with PN in September, making it an option for an estimated 75,000 patients with the condition, and adding to the drug's earlier approvals in atopic ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...